BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lee WM, King WC, Schwarz KB, Rule J, Lok ASF; HBRN Investigators. Prevalence and clinical features of patients with concurrent HBsAg and anti-HBs: Evaluation of the hepatitis B research network cohort. J Viral Hepat 2020;27:922-31. [PMID: 32364641 DOI: 10.1111/jvh.13312] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
Number Citing Articles
1 Shaver ZM, Anderson M, Bhebhe L, Baruti K, Choga WT, Ngidi J, Mbangiwa T, Tau M, Setlhare DR, Melamu P, Phinius BB, Musonda R, Mine M, Moyo S, Gaseitsiwe S. Decreased hepatitis B virus vaccine response among HIV-positive infants compared with HIV-negative infants in Botswana. AIDS 2022;36:755-62. [PMID: 35113045 DOI: 10.1097/QAD.0000000000003183] [Reference Citation Analysis]
2 Nagra N, Kozarek RA, Burman BE. Therapeutic Advances in Viral Hepatitis A-E. Adv Ther 2022;39:1524-52. [PMID: 35220557 DOI: 10.1007/s12325-022-02070-z] [Reference Citation Analysis]
3 Vanwolleghem T, Adomati T, Van Hees S, Janssen HL. Humoral immunity in hepatitis B virus infection: Rehabilitating the B in HBV. JHEP Reports 2022;4:100398. [DOI: 10.1016/j.jhepr.2021.100398] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
4 Vasconcelos J, Domingos J, Bastos L, Baptista T, Mansinho K. Pegylated Interferon Alpha for Chronic Hepatitis B Virus Infection. Case Rep Infect Dis 2022;2022:3890309. [PMID: 35036013 DOI: 10.1155/2022/3890309] [Reference Citation Analysis]
5 Jiang X, Chang L, Yan Y, Wang L. Paradoxical HBsAg and anti-HBs coexistence among Chronic HBV Infections: Causes and Consequences. Int J Biol Sci 2021;17:1125-37. [PMID: 33867835 DOI: 10.7150/ijbs.55724] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]